CYCLOHEXYLMETHANSULFONAMIDE

European patent · EP3122731 · In force

Register entry

Publication number
EP3122731
Application number
EP15713431
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 25, 2015
Published
Feb 1, 2017
Granted
Oct 10, 2018
Protection ends at the latest
Mar 24, 2035
Next annual fee due
Mar 31, 2027
IPC classes
C07D 239/46 (2006.01)
C07D 471/04 (2006.01)
C07D 471/14 (2006.01)
C07D 473/34 (2006.01)
C07D 487/04 (2006.01)
C07D 495/04 (2006.01)
A61K 31/44 (2006.01)
A61K 31/50 (2006.01)
A61K 31/505 (2006.01)
A61K 31/52 (2006.01)
Priority
EP 14162391 28.03.2014
PCT application
PCT/EP2015/056430 25.03.2015
PCT publication
WO2015/144773 01.10.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Dec 20, 2023

    Address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 20.12.2023

  5. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  6. Dec 31, 2020

    Pledge entered

    Pledgee
    Goldman Sachs Bank USA, 200 West Street, New York, NY 10282, USA

    Published in Swissreg on 31.12.2020

  7. Nov 7, 2018

    Agent entered

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 07.11.2018

  8. Oct 10, 2018

    Granted

    Published in Swissreg on 10.10.2018

Parties

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.